中文 | English
Return
Total: 190 , 1/19
Show Home Prev Next End page: GO
Author:(Ying-Ke XU)

1.Efficacy of sequential or combined amphotericin B and fluconazole therapy in non-acquired immunodeficiency syndrome-related cryptococcal meningitis

Ying YAN ; Li MAI ; Wenxiong XU ; Weimin KE ; Qihuan XU

Chinese Journal of Infectious Diseases 2013;(5):295-298

2.Effect of fluoride concentration on the corrosion behavior of cobalt-chromium alloy fabricated by two different technology processes.

Qiuxia YANG ; Ying YANG ; Han XU ; Di WU ; Ke GUO

West China Journal of Stomatology 2016;34(1):47-53

3.Ketogenic diet therapy in the epilepsy of infancy with migrating focal seizures associated with TBC1D24 gene mutation: two case reports and literature review

Jun HU ; Zhongling KE ; Ying XU ; Zheng CHEN ; Yanhui CHEN

Chinese Journal of Neurology 2021;54(6):567-573

4.Influencing factors for complete resection and operation time in endoscopic submucosal dissection for colorectal tumors

Mei HAN ; Ying LI ; Jing ZHAN ; Ke TAO ; Hong XU

Chinese Journal of Digestive Endoscopy 2017;34(2):122-126

5.Progress in a relevant role of sirtuins in age-related cataract

Ying, SUN ; Shu-Bin, WU ; Ke, XU ; Zhi-Jian, LI

International Eye Science 2015;(4):618-620

6.Correlation between PAK1 gene polymorphism and prognosis of endocrine therapy for breast cancer

ke-ji, ZHANG ; ying-chun, XU ; feng-chun, ZHANG

Journal of Shanghai Jiaotong University(Medical Science) 2006;0(09):-

7.Construction of an immortalized rat astrocyte strain with inducible enkephalin expression

Ying XU ; Yu-Ke TIAN ; Xue-Bi TIAN ;

Chinese Journal of Anesthesiology 1994;0(06):-

9.LncRNA LINC00261 regulates radiosensitivity of nasopharyngeal carcinoma and tumor formation in nude mice by down-regulating miR-620 expression

Gaoshang FU ; Ke ZHANG ; Yanxia XU ; Ying XU ; Xuexi ZHANG ; Lixia LIAN

Chinese Journal of Radiation Oncology 2021;30(2):198-203

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 190 , 1/19 Show Home Prev Next End page: GO